PA Consulting Group
This page was last edited on at
PA Consulting Group is an international consulting and technology company, headquartered in the UK.1
Background
The company was the second-largest recipient of UK Government contracts to consulting firms in 2010, behind Deloitte and ahead of KPMG.2 According to contractsfinder.service.gov.uk, PA Consulting’s most-recent contracts with the Government, both ended in March 2017.34.
Investigated by the National Audit Office
In June 2015 the National Audit Office (NAO) was notified by UK Trade and Investment (UKTI); a Government department (replaced by the Department for international Trade in 20165), of potential issues with the transparency and accuracy of PA Consulting Group’s charges in relation to a contract that it held with UKTI. This led to a NAO investigation which found that:
“both UKTI and PA have fallen well below the standards expected in managing public money… PA should have been more transparent in its dealings with UKTI… UKTI should have been able to rely on PA to be transparent regarding changes in its pricing and how it was disclosing its profit on the contract.”6
Relationship with the Tobacco Industry
PA Consulting Group worked with British American Tobacco (BAT) on supporting the tracking and tracing of tobacco products through the supply chain in 2009,7 on a customer service strategy in 2012,8 and on facilitating packaging modifications in accordance with the European Tobacco Products Directive in 2014.9
As of August 2017, PA Consulting’s website stated that the company “are now supporting BAT in their next anti-illicit trade development project.”10 BAT has a history of involvement in tobacco smuggling. For more information see: BAT Involvement in Tobacco Smuggling
Views on Public Health Policy: Promoting Private-Public Partnerships
In addition to its work on illicit tobacco, PA Consulting Group has expressed an opinion on the topic of preventing illicit pharmaceuticals, stating that:
“it requires a strong private-public partnership… (involving) combined initiatives from policy makers, enforcement agencies, and companies to implement appropriate brand protection technologies”.11
An article on its website suggests that the pharmaceutical industry should follow in the steps of the tobacco industry when attempting to deal with illicit trade, putting forward ’10 lessons that the Pharma industry Can Learn From Tobacco’. The list includes suggestions such as “make sure the industry gets involved” and “collaborate with the public sector”.12
In 2014, a PA Consulting Group representative wrote a letter to the editor of the British Medical Journal regarding alcohol pricing claiming that:
“We seem to have adopted a Manichean worldview, where gallant public health scientists fight an industry that wields enormous power over government and cares not for the health of its customers. This attitude will not lead to good public health policies… Then there is the allegation that industry has conspired to corrupt the evidence on pricing. It implies that we can’t trust any opposition because most will have been sponsored by industry vested interests. No doubt we should be wary of lobbying, but we should also judge arguments on their merit and not their sponsor.”13
Other Affiliations
All Party Parliamentary Group on Illicit Trade
On 23 August 2017 it was announced that PA Consulting Group would be providing “expert advice” to the (APPG) on illicit trade.1415 For more information on the APPG and PA Consulting’s role with it see: (APPG) on illicit trade.